The researchers found that people who were economically deprived, even in the absence of sickle cell disease, had more ...

Columnist Oluwatosin Adesoye had faced many sickle cell complications, but her hypothyroidism diagnosis was, at first, ...

Columnist Mary Shaniqua, who undergoes monthly transfusions because of sickle cell, thanks the blood donors who make it ...

Richard Bayliss is 44 years old and has sickle cell disease with hemoglobin SS disease. He’s in the final year of a master’s ...

Stem cell transplant in young adults and adolescents with severe sickle cell disease may be a feasible option, according to a ...

After moving from Sierra Leone to London, guest columnist Richard Bayliss received a proper diagnosis and care plan for his sickle cell.

Immvention Therapeutix is partnering with Novo Nordisk to develop oral treatments for sickle cell disease (SCD) and other chronic conditions.

Fulcrum Therapeutics is planning to report, by midyear, new data from the ongoing PIONEER Phase 1b clinical trial that’s testing its oral therapy candidate pociredir (FTX-6058) in people with sickle ...